Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib .
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib . |
Synonyms | OSI-774 D6, NSC 718781 D6, CP-358774 D6 |
Molecular Weight | 399.47 |
Formula | C22H23N3O4 |
CAS No. | 1034651-23-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Erlotinib-d6 1034651-23-4 Others OSI-774 D6 Erlotinib-d-6 Erlotinib d6 NSC 718781 D6 Erlotinibd6 CP-358774 D6 inhibitor inhibit